# Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases

> **NCT02992249** · — · COMPLETED · sponsor: **Avita Medical** · enrollment: 100 (actual)

## Conditions studied

- Burns

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02992249
- **Lead sponsor:** Avita Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2019-05
- **Final completion:** 2020-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992249, "Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02992249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*